One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration

One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration

Purpose. To evaluate the effects of photodynamic therapy (PDT) combined with intravitreal injection of ranibizumab (IVR) for exudative age-related macular degeneration (AMD). Methods. Retrospective case series. Thirty eight eyes of 38 patients with exudative AMD underwent combined therapy consisting...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tomoko Nakamura, Akio Miyakoshi, Kazuya Fujita, Tatsuya Yunoki, Keiichi Mitarai, Shuichiro Yanagisawa, Chiharu Fuchizawa, Atsushi Hayashi
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2012/154659
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of OCT Angiography Parameters after Administration of Intravitreal Brolucizumab versus Ranibizumab in Exudative Age-related Macular Degeneration
by: Sanjitha Vilma Moses, et al.
Published: (2024-12-01)

Intravitreal Ranibizumab versus Razumab in treatment naïve diabetic macular edema
by: Dhandapani A, et al.
Published: (2025-06-01)

Comparison of Intravitreal Dexamethasone Implant and Ranibizumab in Vitrectomized Eyes with Diabetic Macular Edema
by: Jia-Kang Wang, et al.
Published: (2021-01-01)

Evaluation of topical bromfenac as an adjunctive treatment with intravitreal ranibizumab in the management of diabetic macular edema
by: Sara S. Emara, et al.
Published: (2024-10-01)

Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration
by: Beata Urban, et al.
Published: (2020-01-01)

Visual Performance in Patients with Neovascular Age-Related Macular Degeneration Undergoing Treatment with Intravitreal Ranibizumab
by: Sarah Sabour-Pickett, et al.
Published: (2013-01-01)

Early Responses to Intravitreal Ranibizumab in Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
by: Wataru Matsumiya, et al.
Published: (2011-01-01)

Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion
by: Marcel N. Menke, et al.
Published: (2016-01-01)

Successful Resolution of Preretinal Haemorrhage with Intravitreal Ranibizumab
by: Baharuddin Noorlaila, et al.
Published: (2016-01-01)

Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2014-07-01)

Effect of combined mature cataract surgery and intravitreal ranibizumab injection in eyes with pre-existing diabetic macular edema
by: Yao Shen, et al.
Published: (2025-08-01)

Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
by: Patricia Udaondo, et al.
Published: (2011-01-01)

Pars Plana Vitrectomy versus Intravitreal Injection of Ranibizumab in the Treatment of Diabetic Macular Edema Associated with Vitreomacular Interface Abnormalities
by: Hassan Elkayal, et al.
Published: (2021-01-01)

Effects of Intravitreal Ranibizumab Injection on Chinese Patients with Wet Age-Related Macular Degeneration: 5-Year Follow-Up Results
by: Yingyi Lu, et al.
Published: (2016-01-01)

Clinical Efficacy of Intravitreal Ranibizumab in Early and Mid-Idiopathic Choroidal Neovascularization
by: Chuanfeng Fan, et al.
Published: (2014-01-01)

Intravitreal Ranibizumab for Treatment of Posttraumatic Choroidal Neovascularization: a Case Report
by: A. N. Kulikov, et al.
Published: (2021-10-01)

Effects of a single intravitreal injection of aflibercept and ranibizumab on glomeruli of monkeys.
by: Alexander Tschulakow, et al.
Published: (2014-01-01)

Managing Choroidal Neovascularization in Pseudoxanthoma Elasticum: Outcomes of Vitrectomy and Intravitreal Ranibizumab/Aflibercept Therapy—A Case Report
by: Kazuya Yamashita, et al.
Published: (2025-01-01)

Short-term impact of glycaemic control and intravitreal ranibizumab treatment on serum cytokine levels and diabetic macular edema in patients with unregulated blood glucose
by: Hürkan Kerimoğlu, et al.
Published: (2022-12-01)

The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome
by: A. M. Kolomeyer, et al.
Published: (2011-01-01)

Asymmetric Outcomes of Type 1 Retinopathy of Prematurity after Bilateral Intravitreal Ranibizumab Treatment
by: Qiujing Huang, et al.
Published: (2017-01-01)

Intravitreal Ranibizumab Alone or in Combination with Calcium Dobesilate for the Treatment of Diabetic Macular Edema in Nonproliferative Diabetic Retinopathy Patients: 12-Month Outcomes of a Retrospective Study
by: Dongxuan Wang, et al.
Published: (2022-01-01)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
by: Alfredo García-Layana, et al.
Published: (2015-01-01)

Two-Years Real-World Experience of a Tertiary Center with Intravitreal Brolucizumab Switch for Treatment of Exudative Neovascular Age-Related Macular Degeneration
by: Federico Beretta, et al.
Published: (2025-04-01)

Outcome of optic disc capillary hemangioma following intravitreal ranibizumab injection: A case report
by: Miao Hao, et al.
Published: (2025-04-01)

Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report
by: Panagiotis G. Mitropoulos, et al.
Published: (2014-01-01)

Macular Morphological Changes in Familial Exudative Vitreoretinopathy with Macular Traction on OCT
by: Asaki Hirai, et al.
Published: (2025-03-01)

OCT macular changes in type 1 ROP following Ranibizumab injections
by: Rawan Hosny, et al.
Published: (2025-04-01)

Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema
by: Valérie Sarda, et al.
Published: (2020-01-01)

Acute inflammatory demyelinating polyneuropathy shortly after administration of intravitreal ranibizumab: A clinical and electrophysiological annotation
by: J. Berciano, et al.
Published: (2025-07-01)

Intravitreal Ranibizumab Injection as an Adjuvant in the Treatment of Neovascular Glaucoma Accompanied by Vitreous Hemorrhage after Diabetic Vitrectomy
by: Xi Shen, et al.
Published: (2016-01-01)

Cystoid macular edema in peripheral exudative hemorrhagic chorioretinopathy
by: Daraius Shroff, et al.
Published: (2025-01-01)

Systemic Associations with Residual Subretinal Fluid after Ranibizumab in Diabetic Macular Edema
by: Meng-Ju Tsai, et al.
Published: (2017-01-01)

Real-World Treatment Patterns and Vision Outcomes with Ranibizumab for Diabetic Macular Edema
by: Tadas Naujokaitis, et al.
Published: (2021-01-01)

Analysis of intravitreal using of anti vegf-medications for diseases of fundus accompanied by exudation and neovascularization
by: N. G. Zavgorodnya, et al.
Published: (2013-08-01)

Effect of simultaneous intravitreal ranibizumab and extended-release dexamethasone injection on patients with naïve versus refractory retinal vein occlusion macular edema: a prospective, multicenter, and interventional open-label study
by: Yao-Yao Sun, et al.
Published: (2025-05-01)

Diabetic Macular Edema in Maintenance Intravitreal Scheduling
by: Enzo Maria Vingolo, et al.
Published: (2025-05-01)

Clinical Response To Switch From Ranibizumab To Aflibercept In Wet Age-Related Macular Degeneration
by: Bhagya Weerasinghe, et al.
Published: (2021-01-01)

Macular Hole Progression following Ocriplasmin Intravitreal Injection
by: Edward Casswell, et al.
Published: (2014-01-01)

Intravitreal bevacizumab for neovascular age-related macular degeneration
by: Junn R. Pajarillo, MD, et al.
Published: (2009-12-01)